Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
395
Employees395
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
395
Employees395

ARDX Key Statistics

Market cap
1.21B
Market cap1.21B
Price-Earnings ratio
-21.37
Price-Earnings ratio-21.37
Dividend yield
Dividend yield
Average volume
3.59M
Average volume3.59M
High today
$5.06
High today$5.06
Low today
$4.84
Low today$4.84
Open price
$5.02
Open price$5.02
Volume
2.53M
Volume2.53M
52 Week high
$6.78
52 Week high$6.78
52 Week low
$3.21
52 Week low$3.21

ARDX News

Simply Wall St 24h
A Look at Ardelyx’s Valuation Following CFO Appointment and Strategic Leadership Shift

Ardelyx (ARDX) just named Sue Hohenleitner as its next Chief Financial Officer, tapping into her decades of experience at Johnson & Johnson. This leadership cha...

A Look at Ardelyx’s Valuation Following CFO Appointment and Strategic Leadership Shift
TipRanks 3d
Ardelyx Appoints New CFO Sue Hohenleitner

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 4d
Will Ardelyx’s New CFO Appointment Signal a Shift in Financial Strategy and Growth Priorities?

Ardelyx announced the upcoming appointment of Sue Hohenleitner as Chief Financial Officer, effective November 4, 2025, following the completion of its third qua...

Will Ardelyx’s New CFO Appointment Signal a Shift in Financial Strategy and Growth Priorities?

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

More ARDX News

TipRanks 4d
Ardelyx appoints Hohenleitner as Chief Financial Officer

Ardelyx (ARDX) (ADRX) announced the appointment of Sue Hohenleitner as Chief Financial Officer, CFO, effective November 4, 2025. Hohenleitner most recently serv...

Simply Wall St 6d
Ardelyx, Inc. Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

The Ardelyx, Inc. ( ) share price has softened a substantial 26% over the previous 30 days, handing back much of the gains the stock has made lately. The drop o...

Ardelyx, Inc. Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.